LRRC6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test sale cost 4400 AED
MAP1A Gene Hearing Loss MAP1A Related Genetic Test sale cost 4400 AED MAP1A Gene Hearing Loss MAP1A Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DNAH9 Gene Primary Ciliary Dyskinesia DNAH9 Related Genetic Test sale cost 4400 AED DNAH9 Gene Primary Ciliary Dyskinesia DNAH9 Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

LRRC6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LRRC6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the LRRC6 gene which are associated with Primary Ciliary Dyskinesia (PCD) Type 19. PCD is a rare genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and fertility issues, resulting from defective ciliary structure and function. The LRRC6 gene plays a crucial role in the development and function of cilia, which are microscopic, hair-like structures on the surface of cells, essential for movement and signaling.

This genetic test is pivotal for individuals exhibiting symptoms of PCD, or those with a family history of the condition, as it provides definitive diagnosis by detecting mutations in the LRRC6 gene. Early and accurate diagnosis through this test can significantly improve management and treatment strategies, enhancing the quality of life for affected individuals.

The test is conducted at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing capabilities and adherence to international standards. The cost of the LRRC6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test is 4400 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed.

Individuals undergoing this test can expect a simple, non-invasive procedure, typically involving a blood sample or cheek swab, which is then analyzed using cutting-edge genetic sequencing techniques to identify mutations in the LRRC6 gene. Results from this test not only aid in diagnosis but also help in understanding the genetic basis of the condition, facilitating informed decisions regarding family planning for those carrying the gene mutation.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LRRC6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test

At DNA Labs UAE, we offer the LRRC6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test for individuals who suspect they may have primary ciliary dyskinesia type 19 (PCD19), a genetic disorder affecting the functioning of cilia.

Test Components

The LRRC6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test includes:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA17

About LRRC6 Gene Primary Ciliary Dyskinesia Type 19

The LRRC6 gene is associated with primary ciliary dyskinesia type 19 (PCD19), a genetic disorder that affects the functioning of cilia. Cilia are tiny hair-like structures found on the surface of cells, particularly in the respiratory tract, reproductive organs, and the brain.

PCD19 is characterized by the following symptoms:

  • Chronic respiratory tract infections, such as bronchiectasis and sinusitis
  • Infertility in males due to impaired sperm motility
  • Chronic ear infections
  • Hearing loss
  • Situs inversus (where the internal organs are mirrored from their normal positions)

NGS Genetic Testing

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze a person’s DNA to identify mutations or variations in specific genes associated with a particular disorder. In the case of PCD19, NGS genetic testing can be used to detect mutations in the LRRC6 gene, helping to confirm a diagnosis of primary ciliary dyskinesia type 19.

It is important to note that genetic testing should be conducted by a healthcare professional who specializes in genetics, and the results should be interpreted in the context of a person’s overall clinical presentation and family history. Genetic counseling may also be recommended to discuss the implications and potential risks associated with the test results.

Test Name LRRC6 Gene Primary ciliary dyskinesia type 19 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA17
Test Details

The LRRC6 gene is associated with primary ciliary dyskinesia type 19 (PCD19), which is a genetic disorder that affects the functioning of cilia. Cilia are tiny hair-like structures found on the surface of cells, particularly in the respiratory tract, reproductive organs, and the brain.

PCD19 is characterized by chronic respiratory tract infections, such as bronchiectasis and sinusitis, as well as infertility in males due to impaired sperm motility. Other symptoms may include chronic ear infections, hearing loss, and situs inversus (where the internal organs are mirrored from their normal positions).

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze a person’s DNA to identify mutations or variations in specific genes associated with a particular disorder. In the case of PCD19, NGS genetic testing can be used to detect mutations in the LRRC6 gene, helping to confirm a diagnosis of primary ciliary dyskinesia type 19.

It is important to note that genetic testing should be conducted by a healthcare professional who specializes in genetics, and the results should be interpreted in the context of a person’s overall clinical presentation and family history. Genetic counseling may also be recommended to discuss the implications and potential risks associated with the test results.

SKU: TEST-2776 Category:

Related products